EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
4.3.1.4 | Carcinoma, Hepatocellular |
18571811 |
Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 1 0 |
4.3.1.4 | Carcinoma, Hepatocellular |
31203308 |
Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway. |
causal interaction therapeutic application unassigned |
4 1 0 |
4.3.1.4 | Hepatitis, Autoimmune |
10029623 |
Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. |
causal interaction diagnostic usage unassigned |
4 3 0 |
4.3.1.4 | Hepatitis, Autoimmune |
11983223 |
Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein. |
causal interaction unassigned |
1 0 |
4.3.1.4 | Infections |
23475565 |
Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells. |
ongoing research therapeutic application unassigned |
3 1 0 |
4.3.1.4 | Infections |
27974250 |
The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development. |
ongoing research therapeutic application unassigned |
4 1 0 |
4.3.1.4 | Neoplasms |
18571811 |
Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 1 0 |
4.3.1.4 | Neoplasms |
31203308 |
Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway. |
causal interaction therapeutic application unassigned |
4 1 0 |